Co-Authors
This is a "connection" page, showing publications co-authored by Giacomo Grasselli and Giorgio Berlot.
Connection Strength
0.118
-
Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus. J Clin Med. 2021 Aug 08; 10(16).
Score: 0.060
-
Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum IgM-titres versus standard dose in the treatment of septic shock: a randomised controlled trial (IgM-fat trial). BMJ Open. 2021 02 11; 11(2):e036616.
Score: 0.058